FBT
GILD icon

First Bank & Trust’s Gilead Sciences GILD Stock Holding History

First Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Sell
21,831
-6,178
-22% -$814K 0.41% 54
2026
Q1 		$3.9M Sell
28,009
-8,572
-23% -$1.2M 0.63% 38
2025
Q4 		$4.49M Sell
36,581
-2,761
-7% -$336K 0.73% 25
2025
Q3 		$4.37M Sell
39,342
-4,494
-10% -$511K 0.73% 27
2025
Q2 		$4.86M Sell
43,836
-6,601
-13% -$703K 0.87% 18
2025
Q1 		$5.65M Sell
50,437
-1,492
-3% -$154K 1.09% 15
2024
Q4 		$4.8M Buy
51,929
+354
+0.7% +$31.9K 0.92% 18
2024
Q3 		$4.32M Buy
51,575
+1,570
+3% +$120K 0.82% 23
2024
Q2 		$3.43M Buy
50,005
+11,736
+31% +$783K 0.7% 28
2024
Q1 		$2.8M Buy
38,269
+2,569
+7% +$198K 0.58% 39
2023
Q4 		$2.89M Sell
35,700
-1,210
-3% -$94.2K 0.7% 33
2023
Q3 		$2.77M Sell
36,910
-771
-2% -$59.3K 0.72% 29
2023
Q2 		$2.9M Sell
37,681
-3,892
-9% -$310K 0.74% 28
2023
Q1 		$3.45M Sell
41,573
-21,341
-34% -$1.77M 0.91% 14
2022
Q4 		$5.4M Buy
62,914
+1,538
+3% +$122K 1.5% 11
2022
Q3 		$3.79M Buy
61,376
+3,822
+7% +$241K 1.39% 12
2022
Q2 		$3.56M Buy
57,554
+7,892
+16% +$489K 1.16% 14
2022
Q1 		$2.95M Buy
49,662
+6,465
+15% +$413K 0.91% 22
2021
Q4 		$3.14M Buy
43,197
+285
+0.7% +$19.6K 1.32% 11
2021
Q3 		$3M Buy
42,912
+640
+2% +$45K 1.37% 13
2021
Q2 		$2.91M Buy
42,272
+300
+0.7% +$20K 1.4% 12
2021
Q1 		$2.71M Buy
41,972
+3,448
+9% +$222K 1.37% 15
2020
Q4 		$2.25M Buy
38,524
+12,636
+49% +$762K 1.42% 15
2020
Q3 		$1.64M Buy
25,888
+335
+1% +$23.2K 1.09% 25
2020
Q2 		$1.97M Sell
25,553
-11,755
-32% -$901K 1.48% 15
2020
Q1 		$2.79M Buy
37,308
+7,758
+26% +$536K 2.51% 4
2019
Q4 		$1.92M Buy
29,550
+1,686
+6% +$110K 1.4% 17
2019
Q3 		$1.77M Buy
27,864
+26,519
+1,972% +$1.73M 1.33% 18
2019
Q2 		$91K Sell
1,345
-430
-24% -$28.3K 0.07% 176
2019
Q1 		$115K Sell
1,775
-321
-15% -$21.3K 0.09% 170
2018
Q4 		$131K Buy
2,096
+72
+4% +$5.03K 0.11% 158
2018
Q3 		$154K Sell
2,024
-25
-1% -$1.89K 0.12% 164
2018
Q2 		$145K Buy
2,049
+88
+4% +$6.21K 0.11% 164
2018
Q1 		$148K Hold
1,961
– – 0.12% 159
2017
Q4 		$140K Buy
1,961
+119
+6% +$9.04K 0.11% 159
2017
Q3 		$149K Buy
1,842
+122
+7% +$9.33K 0.12% 153
2017
Q2 		$122K Sell
1,720
-5
-0.3% -$333 0.1% 158
2017
Q1 		$117K Sell
1,725
-239
-12% -$16.8K 0.1% 167
2016
Q4 		$140K Buy
+1,964
New +$146K 0.13% 153

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

First Bank & Trust's GILD Position: Q2 2026 in Review

First Bank & Trust reduced its Gilead Sciences (GILD) stake by 22% in Q2 2026, selling an estimated $814K and leaving 21,831 shares worth $2.76M. The position accounts for 0.41% of the portfolio, ranked #54.

First Bank & Trust first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $5.65M in Q1 2025. 428 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First Bank & Trust held 21,831 shares of Gilead Sciences worth $2.76M as of Q2 2026.
  • First Bank & Trust sold 6,178 Gilead Sciences shares in Q2 2026, an estimated $814K.
  • Gilead Sciences made up 0.41% of First Bank & Trust's portfolio in Q2 2026, its #54 holding.
  • First Bank & Trust first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
  • First Bank & Trust's Gilead Sciences position peaked at $5.65M in Q1 2025.
  • 428 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.